The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.

Flack, J M; Yunis, C; Preisser, J; Holmes, C B; Mensah, G; McLean, B; Saunders, E

Flack, J M; Yunis, C; Preisser, J; Holmes, C B; Mensah, G; McLean, B; Saunders, E.

Affiliation

Flack JM; Department of Internal Medicine, Wayne State University Medical School, the Detroit Medical Center, Mich 48201, USA. jflack@intmed.wayne.edu

Arch Intern Med ; 160(12): 1842-7, 2000 Jun 26.

Article in En | MEDLINE | ID: mdl-10871979

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/administration & dosage; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Antihypertensive Agents/administration & dosage; Antihypertensive Agents/adverse effects; Blood Pressure/drug effects; Hypertension/drug therapy; Hypertension/physiopathology; Isoquinolines/administration & dosage; Isoquinolines/adverse effects; Tetrahydroisoquinolines; Adult; Aged; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Quinapril; Severity of Illness Index; Southeastern United States; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Pressure / Angiotensin-Converting Enzyme Inhibitors / Tetrahydroisoquinolines / Hypertension / Isoquinolines / Antihypertensive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Arch Intern Med Year: 2000 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links